Lower-dose dexamethasone (Dex)/thalidomide (Thal) and zoledronic acid (ZOL) every 3 weeks in previously untreated multiple myeloma. Background: OFA is a human IgG 1 monoclonal antibody that recognizes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results